We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CMPX market cap is 152.72M. The company's latest EPS is USD -0.3088 and P/E is -3.56.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 3.93M | 0 | 0 | 0 |
| Operating Income | -9.71M | -9.4M | -11.93M | -15.39M | -12.77M |
| Net Income | -7.84M | -11.28M | -9.96M | -13.42M | -10.79M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -32k | -27.81M | -81.88M | -41.66M | -50.36M |
| Net Income | -37k | -29.5M | -82.18M | -39.23M | -42.49M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 187.98M | 179.18M | 170.04M | 156.88M | 161.14M |
| Total Liabilities | 12.71M | 10.9M | 9.99M | 8.34M | 4.08M |
| Total Equity | 175.27M | 168.29M | 160.05M | 148.54M | 157.06M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4k | 51.91M | 153.76M | 199.65M | 156.88M |
| Total Liabilities | 112k | 11.97M | 13.68M | 18.01M | 8.34M |
| Total Equity | -108k | 39.95M | 140.08M | 181.64M | 148.54M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.23M | -22.34M | -28.26M | -40.62M | -13.89M |
| Investing | 4.27M | 3.6M | 20.65M | 26.97M | -4.1M |
| Financing | 41k | 3.07M | 3.09M | 2.94M | 17.43M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31k | -26.8M | -19.67M | -34.13M | -40.62M |
| Investing | N/A | 38k | -1.77M | -151.2M | 26.97M |
| Financing | 31k | 48.54M | 118.61M | 75.76M | 2.94M |
| Market Cap | 152.72M |
| Price to Earnings Ratio | -3.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.25 |
| Price to Book Ratio | 1.02 |
| Dividend Yield | - |
| Shares Outstanding | 137.59M |
| Average Volume (1 week) | 569.81k |
| Average Volume (1 Month) | 330.99k |
| 52 Week Change | -65.31% |
| 52 Week High | 3.42 |
| 52 Week Low | 1.06 |
| Spread (Intraday) | 0.06 (5.22%) |
| Company Name | Compass Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.compasstherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
